SKK
NURO

Shepherd Kaplan Krochuk’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11
Closed -$68K – 630
2014
Q1 		$68K Buy
+11
New +$70.8K 0.01% 553

Other funds holding NURO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Shepherd Kaplan Krochuk's NURO Position: Q2 2014 in Review

Shepherd Kaplan Krochuk sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2014, closing a stake of 11 shares — an estimated $68K sold.

Shepherd Kaplan Krochuk first reported a position in NURO in Q1 2014 and held it in 1 quarter. The position peaked at $68K in Q1 2014. 8 funds tracked by Wall St. Rank hold NURO as of Q2 2014.

  • Shepherd Kaplan Krochuk reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 11 NeuroMetrix, Inc. Common Stock shares in Q2 2014, an estimated $68K.
  • Shepherd Kaplan Krochuk first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • Shepherd Kaplan Krochuk's NeuroMetrix, Inc. Common Stock position peaked at $68K in Q1 2014.
  • 8 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2014, filed 14 Aug 2014.